Search

The Basser Center is raising awareness about hereditary cancer through our #INVISIBLEGENES social media campaign and we need your help! The traits we inherit from our family define and connect us in countless ways. Sometimes these traits are obvious, like curly hair or dimples. But sometimes what we inherit remains hidden, like BRCA gene mutations which can increase your risk for developing certain type of cancers.

In this month’s profile, get to know Basser Young Leadership Council member Kevin Kucharski, a BRCA2 mutation carrier and medical student.

Phil Basser, patriarch of the Basser family, has recently made it into the news for his legendary love of the Philadelphia Eagles.

A phase II clinical trial that began in August of 2017, “A Phase 2, Open Label Study of Rucaparib in Patients With Advanced Pancreatic Cancer and a Known Deleterious Germline or Somatic BRCA or PALB2 Mutation,” is enrolling patients at the Hospital of the University of Pennsylvania.

On January 25, the Basser Center for BRCA, UJA-Federation of New York, and the 92nd Street Y teamed up in New York City to present a panel on BRCA mutations and the latest lifesaving information surrounding hereditary cancers.

Learn more about Basser Young Leadership Council member Shannon Hennessy Pulaski, a wife, mother, writer, and BRCA carrier, in this profile.

The Basser Center's internationally recognized experts in cancer genetics, Susan Domchek, MD, and Katherine Nathanson, MD, are working in collaboration with leading experts in the fields of cancer research and genetics in New York, Los Angeles, and Boston to launch the pilot phase of a new, independent research initiative: the BRCA Founder Outreach (BFOR) Study.

The Basser Center's 2018 Breakthroughs and Discoveries Panel brought together some of the world's leading experts in genetic research and hereditary cancer.

This is part one of a summary of a Basser Center panel on the ins and outs of dating with a BRCA mutation.

This is part two of a summary of a Basser Center panel on the ins and outs of dating with a BRCA mutation.

This is part three of a summary of a Basser Center panel on the ins and outs of dating with a BRCA mutation.

In the first in an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.
 

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses early screening recommendations for young women with BRCA mutations, particularly in terms of breast cancer.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses typical guidelines for follow up to a potential recurrence of BRCA-related breast cancer.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses BRCA-related ovarian cancer risk and management options, such as recent research into fallopian tube removal.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses how BRCA mutations impact men, including which cancers they are at hereditary risk for and recommendations for screening.
 

Basser Center Executive Director Susan Domchek, MD, discusses the BFOR Study and the importance of genetic testing for hereditary cancer in the Ashkenazi Jewish community.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses the differences between BRCA1 and BRCA2 mutations and explains how the varying risk factors could impact individuals and their families.